513 related articles for article (PubMed ID: 20009938)
1. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
Sharma P; Sharma BC; Sarin SK
Eur J Gastroenterol Hepatol; 2010 May; 22(5):526-31. PubMed ID: 20009938
[TBL] [Abstract][Full Text] [Related]
2. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
[TBL] [Abstract][Full Text] [Related]
3. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
Sharma P; Sharma BC; Agrawal A; Sarin SK
J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
[TBL] [Abstract][Full Text] [Related]
4. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
Sharma BC; Sharma P; Agrawal A; Sarin SK
Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
[TBL] [Abstract][Full Text] [Related]
5. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
Agrawal A; Sharma BC; Sharma P; Sarin SK
Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
[TBL] [Abstract][Full Text] [Related]
6. Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients.
Bajaj JS; Sanyal AJ; Bell D; Gilles H; Heuman DM
Aliment Pharmacol Ther; 2010 May; 31(9):1012-7. PubMed ID: 20136802
[TBL] [Abstract][Full Text] [Related]
7. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
[TBL] [Abstract][Full Text] [Related]
8. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
[TBL] [Abstract][Full Text] [Related]
9. Profile of hepatic encephalopathy in children with cirrhosis and response to lactulose.
Sharma P; Sharma BC
Saudi J Gastroenterol; 2011; 17(2):138-41. PubMed ID: 21372353
[TBL] [Abstract][Full Text] [Related]
10. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
Teh SH; Sheppard BC; Schwartz J; Orloff SL
Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
[TBL] [Abstract][Full Text] [Related]
11. Lactulose is highly potential in prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
Wen J; Liu Q; Song J; Tong M; Peng L; Liang H
Digestion; 2013; 87(2):132-8. PubMed ID: 23485720
[TBL] [Abstract][Full Text] [Related]
12. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
[TBL] [Abstract][Full Text] [Related]
13. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
Pekow JR; Bhan AK; Zheng H; Chung RT
Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
[TBL] [Abstract][Full Text] [Related]
15. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
[TBL] [Abstract][Full Text] [Related]
16. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy.
Abid S; Jafri W; Mumtaz K; Islam M; Abbas Z; Shah HA; Hamid S
J Coll Physicians Surg Pak; 2011 Nov; 21(11):666-71. PubMed ID: 22078345
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
Huo TI; Lin HC; Lee FY; Hou MC; Lee PC; Wu JC; Chang FY; Lee SD
Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose.
Sharma P; Agrawal A; Sharma BC; Sarin SK
J Gastroenterol Hepatol; 2011 Jun; 26(6):996-1003. PubMed ID: 21129028
[TBL] [Abstract][Full Text] [Related]
20. Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
Tromm A; Griga T; Greving I; Hilden H; Hüppe D; Schwegler U; Micklefield GH; May B
Hepatogastroenterology; 2000; 47(32):473-7. PubMed ID: 10791216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
